Beyond typing and grading: target analysis in individualized therapy as a new challenge for tumour pathology
Oncogenic signaling pathways and deregulated target genes
Predictive pathology of cytostatic drug resistance and new anti-cancer targets
Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract
Resistance-associated signatures in breast cancer
Resistance to chemotherapy in ovarian carcinoma
Clincal, biological, and molecular aspects of metastasis in colorectal cancer
Prediction of efficacy and side effects of chemotherapy in colorectal cancer
Proteomic expression profiling of breast cancer
Targeted therapy and blood-brain barrier
Cetuximab: appraisal of a novel drug against colorectal cancer
C-kit, GIST, and Imatinib
Antibody therapy in no-hodgkin's lymphoma; the role of rituximab, 90Y-ibritumomab tiuxetan, and alemtuzumab
Molecular and clinical aspects of proteasome inhibition in the treatment of cancer
Indiviualized target therapy of malignant lymphomas: an outlook
Antiangiogenesis, anti-VEGF(R) and outlook
Morphological detection of hormone and growth factor receptors in breast cancer
Antigen-specific cancer vaccines
Therapeutic vaccination for the treatment of malignant melanoma
Monoclonal and recombinant antibodies with T cell receptor-like reactivity
New molecular therapy targets in actue myeloid leukemia.